Search research articles
Contact Us
Filters
Showing results (1-10 of 170) with videos related to
Page
of 17
Sort By:
Journal of Cardiovascular Pharmacology
|
October 7, 2020
Introducing Emerging Concepts in Pharmacotherapeutics
Dave L Dixon
The American Journal of Medicine
|
April 4, 2020
Catch of the Day: Icosapent Ethyl for Reducing Cardiovascular Risk
Dave L Dixon
The American Journal of Managed Care
|
December 9, 2022
The impact of PCSK9 modulation on cardiovascular outcomes: recent advances and the managed care implications
Dave L Dixon
Journal of the American Pharmacists Association : Japha
|
March 19, 2021
The student loan debt crisis is undermining our profession
Dave L Dixon
Cardiovascular Diabetology
|
May 30, 2019
The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus
Salvatore Carbone, Dave L Dixon
Expert Opinion on Pharmacotherapy
|
August 17, 2018
Selecting appropriate weight loss pharmacotherapies in older adults to reduce cardiovascular risk
Salvatore Carbone, Dave L Dixon
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Potassium levels in acute myocardial infarction: definitely worth paying attention to
Dave L Dixon, Antonio Abbate
American Heart Journal Plus : Cardiology Research and Practice
|
April 1, 2024
Inclisiran: A knight in shining armor?
Michael Kelly, Dave L Dixon
Diabetes/Metabolism Research and Reviews
|
March 31, 2020
Screening, identification, and management of prediabetes to reduce cardiovascular risk: A missed opportunity?
Dave L Dixon, Salvatore Carbone
Journal of Cardiovascular Pharmacology
|
August 8, 2024
Is Metformin Cardioprotective? A New Piece to the Puzzle
Dave L Dixon, Salvatore Carbone
Page
of 17
Search research articles
Search
Showing results (1-10 of 170) with videos related to
Sort By:
Page
of 17
Journal of Cardiovascular Pharmacology
|
October 7, 2020
Introducing Emerging Concepts in Pharmacotherapeutics
Dave L Dixon
The American Journal of Medicine
|
April 4, 2020
Catch of the Day: Icosapent Ethyl for Reducing Cardiovascular Risk
Dave L Dixon
The American Journal of Managed Care
|
December 9, 2022
The impact of PCSK9 modulation on cardiovascular outcomes: recent advances and the managed care implications
Dave L Dixon
Journal of the American Pharmacists Association : Japha
|
March 19, 2021
The student loan debt crisis is undermining our profession
Dave L Dixon
Cardiovascular Diabetology
|
May 30, 2019
The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus
Salvatore Carbone, Dave L Dixon
Expert Opinion on Pharmacotherapy
|
August 17, 2018
Selecting appropriate weight loss pharmacotherapies in older adults to reduce cardiovascular risk
Salvatore Carbone, Dave L Dixon
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Potassium levels in acute myocardial infarction: definitely worth paying attention to
Dave L Dixon, Antonio Abbate
American Heart Journal Plus : Cardiology Research and Practice
|
April 1, 2024
Inclisiran: A knight in shining armor?
Michael Kelly, Dave L Dixon
Diabetes/Metabolism Research and Reviews
|
March 31, 2020
Screening, identification, and management of prediabetes to reduce cardiovascular risk: A missed opportunity?
Dave L Dixon, Salvatore Carbone
Journal of Cardiovascular Pharmacology
|
August 8, 2024
Is Metformin Cardioprotective? A New Piece to the Puzzle
Dave L Dixon, Salvatore Carbone
Page
of 17